CUSIP: 02290A102
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
17,921,109
-
Share change
-
+1,265,427
-
Total reported value
-
$40,682,047
-
Put/Call ratio
-
593%
-
Price per share
-
$2.27
-
Number of holders
-
16
-
Value change
-
+$8,108,215
-
Number of buys
-
7
-
Number of sells
-
10
Quarterly Holders Quick Answers
What is CUSIP 02290A102?
CUSIP 02290A102 identifies AMAM - AMBRX BIOPHARMA INC - SPONSORED ADS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 02290A102:
Institutional Holders of AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) as of Q4 2022
As of 31 Dec 2022,
AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,921,109 shares.
The largest 10 holders included
Darwin Global Management, Ltd., FMR LLC, Cormorant Asset Management, LP, Artal Group S.A., Fosun International Ltd, ADAGE CAPITAL PARTNERS GP, L.L.C., Alpine Global Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, and B. Riley Wealth Advisors, Inc..
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.